Oncology: Evaluates tumor growth and metastasis in preclinical cancer models
Metabolic pathways don't negotiate
In HR-NB PDX models, the intrinsically chemoresistant LU-NB PDX1 presented an overall higher expression of the antioxidant pathways than the initially responsive LU-NB PDX3 (Fig
Zheng et al., 2023)
The specific site for administration may vary depending on factors such as individual preference, body mass, age, and any underlying medical conditions
Log in EVIDENCE Une revue Cochrane 1 rsume deux essais cliniques randomiss (ECR) 2,3 : Dans la premire tude 2 , 38 patients externes ont t randomiss pour recevoir 2 000 mcg de vitamine B12 par jour par voie orale ou 1 000 mcg de vitamine B12 par voie intramusculaire les 1 er , 3 e , 7 e , 10 e , 14 e , 21 e , 30 e , 60 e et 90 e jours